HOME >> BIOLOGY >> NEWS
University of Toronto professor finds key protein in fight against plant disease

A University of Toronto botanist has identified a protein that ultimately could provide chemical-free ways to protect crops from disease.

"Finding this protein, called DIR1, could help make it possible to genetically engineer crops that resist disease-causing organisms," says Robin Cameron, a professor of botany at U of T and the senior investigator of the study, which appears in the Sept. 26 issue of Nature. "In the long run, having a better understanding of the whole process of disease resistance in plants could eliminate the need for fungicides or bacteriocides."

When disease strikes a plant, its immune system sends up a warning "flare" telling different areas of the plant to resist infection. "This process is kind of like vaccination, only better," Cameron says. Once the signal-dependant on DIR1-is triggered by one disease, it gives the plant systemic acquired resistance (SAR) to many other diseases. The exact role of DIR1 in the signal process is not yet clear, she says.

Cameron, along with colleagues at the Salk Institute in La Jolla, Calif., the John Innes Centre in Norwich, U.K. and the Noble Foundation in Ardmore, Okla., studied a mutant strain of weed with abnormal DIR1 that does not develop SAR when exposed to a certain bacterial disease. "Our studies indicate that the normal protein, DIR1, is required to either make or move the warning signal around the plant," she says.


'"/>

Contact: Nicolle Wahl
nicolle.wahl@utoronto.ca
416-978-6974
University of Toronto
25-Sep-2002


Page: 1

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/12/2017)...  New research undertaken by Fit Small Business ... participants were simply asked which office technology had they not ... standard issue.  Insights on what will be key ... futurists and industry leaders including Penelope Trunk , ... Some of these findings included; ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , February 17, 2017 ... Market by Product (Consumables, Service), Type (Safety, Efficacy, ... Development, Drug Discovery and Development, Disease-Risk) - Global ... is projected to reach USD 53.34 Billion by ... at a CAGR of 13.8% during the forecast ...
(Date:2/16/2017)... ... February 16, 2017 , ... EIT Digital has launched work to ... industry. Pilot studies are about to get under way for the framework, which is ... innovations. The concept is expected to be transferred eventually to other industries that also ...
(Date:2/16/2017)... 16, 2017  ArmaGen, Inc., a privately held ... treat severe neurological disorders, today reported preliminary evidence ... the company,s investigational therapy for the treatment of ... type I, or MPS I). The initial results ... presented today at the 13 th annual ...
(Date:2/16/2017)... 16, 2017 UCHealth ( Aurora, Colorado ... for pulmonary nodule patient management. In addition to optimizing ... spot on the lung, UCHealth looks to improve provider ... entry. Stephanie Brown, RN , Thoracic ... patients with an Excel spreadsheet, which was extremely arduous ...
Breaking Biology Technology:
Cached News: